Polaris AI Pharma Corp. Q3 profit from the main business KRW 52.6 million, down 96.7% from a year earlier
AI summary · Not investment advice
Polaris AI Pharma sold KRW 11.9 billion in Q3 and earned KRW 52.6 million from its main business, down 96.7% from a year earlier and 93.2% from the prior quarter.
Operating profit · 3 months
KRW 52.6 million
Key facts
- Revenue (3 months)
- KRW 11.9 billion
- Net income (3 months)
- KRW -332.8 million
- Period
- Q3 (cumulative 2026.01.01 ~ 2026.09.30)
- Revenue (prior-year 3 months)
- KRW 14.7 billion
- Revenue (year to date)
- KRW 40.3 billion
- Operating profit (prior-year 3 months)
- KRW 1.6 billion
- Operating profit (year to date)
- KRW 1.4 billion
- Net income (prior-year 3 months)
- KRW 3.5 billion
- Net income (year to date)
- KRW 10.1 billion
Commentary
AI commentary · Not investment advice
What happened
Polaris AI Pharma reported its standalone results for the third quarter of 2026. Sales for the 3 months were KRW 11.94 billion. That is 18.8% lower than the same 3 months a year earlier, and also 18.8% lower than the previous quarter.
In the company's terms
Operating profit (profit from the core business) for the 3 months was KRW 52.6 million. That is 96.7% lower than a year earlier and 93.2% lower than the previous quarter. Net income for the 3 months was a loss of KRW 332.8 million. A year earlier, the company had net income of KRW 3.50 billion, so it has swung to a loss. It also swung to a loss compared with the previous quarter.
What changes for shareholders
For the year to date (January 1 to September 30), sales were KRW 40.35 billion. Operating profit was KRW 1.44 billion. Net income was KRW 10.07 billion.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
P